Barrueta A
Health Syst Rev. 1995 Jul-Aug;28(4):20, 22-3.
Like doctors who would legislate less restrictive provider panels at HMOs, some drug makers are trying to muscle their products onto managed care formularies.
就像那些试图在健康维护组织（HMO）制定限制更少的医疗服务提供者名单的医生一样，一些制药商正试图强行将他们的产品纳入管理式医疗药品目录。
